Geographic disparities in chronic obstructive pulmonary disease (COPD) hospitalization among Medicare beneficiaries in the United States

被引:51
|
作者
Holt, James B. [1 ]
Zhang, Xingyou [1 ]
Presley-Cantrell, Letitia [1 ]
Croft, Janet B. [1 ]
机构
[1] US Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
关键词
COPD prevention; environmental risk factors; public health; population; CHRONIC-BRONCHITIS; NATIONAL-HEALTH; AIR-POLLUTION; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; POPULATION; OCCUPATION; MORTALITY; INDUSTRY;
D O I
10.2147/COPD.S19945
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Hospitalizations for persons with chronic obstructive pulmonary disease (COPD) result in significant health care resource use and excess expenditures. Despite well-documented sociodemographic disparities in COPD outcomes, no study has characterized geographic variations in COPD hospitalization across the US. Methods: Almost 3.8 million COPD hospitalization records were extracted from Medicare claims for 1995-2006, and the total population of eligible Medicare beneficiaries was extracted from the Medicare enrollment records to calculate COPD hospitalization rates by Health Service Area (HSA), (n = 949). Spatial cluster analysis and Bayesian hierarchical spatial modeling were used to characterize the geography of COPD hospitalizations. Results: The overall COPD hospitalization rate was 11.30 per 1,000 beneficiaries for the aggregated period 1995-2006. HSA-level COPD hospitalization rates had a median of 11.7 and a range of 3.0 (Cache, UT) to 76.3 (Pike, KY). Excessive hospitalization risk was concentrated in Appalachia, the southern Great Lakes, the Mississippi Delta, the Deep South, and west Texas. In the Bayesian spatial mixture model, 73% of variability of COPD hospitalization relative risk was attributed to unidentified regional social and physical environments shared by HSAs rather than to unique local HSA factors (27%). Conclusion: We discovered distinct geographic patterns in COPD hospitalization rates and risks attributed to both regionally-shared environmental risk factors and HSA-unique environmental contexts. The correlates of these geographic patterns remain to be determined. Geographic comparisons of COPD hospitalization risk provide insights for better public health practice, policies, and programs for COPD prevention.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [21] PREDICTORS OF NEBULIZED ARFORMOTEROL USE: A RETROSPECTIVE ANALYSIS AMONG MEDICARE BENEFICIARIES WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Gilmer, T. P.
    Ganapathy, V
    Xu, Z.
    Celli, B. R.
    Sharma, G.
    Cho-Reyes, S.
    Navaie, M.
    VALUE IN HEALTH, 2017, 20 (05) : A206 - A207
  • [22] Albuterol and Levalbuterol Use and Spending in Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease
    Puig, Andrea
    McElligott, Sean
    Bergquist, Henry
    Doshi, Jalpa A.
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (06): : 571 - 582
  • [23] COMORBIDITIES IN MEDICARE OLDER ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Le, T.
    Qato, D. M.
    Magder, L.
    Bjarnadottir, M.
    Zafari, Z.
    Simoni-Wastila, L.
    VALUE IN HEALTH, 2020, 23 : S356 - S356
  • [24] DIRECT INCREMENTAL COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA IN THE UNITED STATES
    Patel, B. B.
    Kamal, K. M.
    Kanyongo, G.
    Elliot, J. L.
    VALUE IN HEALTH, 2012, 15 (04) : A54 - A54
  • [25] Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
    Valvi, Deepa
    Mannino, David M.
    Muellerov, Hana
    Tal-Singer, Ruth
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 173 - 182
  • [26] JAMA Infographic Prevalence and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in the United States
    Biener, Adam I.
    Decker, Sandra L.
    Rohde, Frederick
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (07): : 602 - 602
  • [27] Prevalence of Multiple Chronic Conditions Among Medicare Beneficiaries, United States, 2010
    Lochner, Kimberly A.
    Cox, Christine S.
    PREVENTING CHRONIC DISEASE, 2013, 10 : 1 - 10
  • [28] Incremental Mortality Associated with Nontuberculous Mycobacterial Lung Disease Among US Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease
    Wang, P.
    Marras, T. K.
    Alemao, E.
    Hassan, M.
    Chatterjee, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [29] Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease
    Ping Wang
    Theodore K. Marras
    Mariam Hassan
    Anjan Chatterjee
    BMC Infectious Diseases, 23
  • [30] Geographic Disparity in Chronic Obstructive Pulmonary Disease (COPD) Mortality Rates among the Taiwan Population
    Chan, Ta-Chien
    Chiang, Po-Huang
    Su, Ming-Daw
    Wang, Hsuan-Wen
    Liu, Michael Shi-yung
    PLOS ONE, 2014, 9 (05):